February NICE Guidance
February 28, 2008 on 4:51 pm | In Prescribing Extra - Other |
Print
|
The National Institute of Health and Clinical Excellence has published new guidance for the month of February.
The published guidance includes Clinical Guidelines that cover Irritable bowel syndrome (IBS), osteoarthritis (OA) and prostate cancer.
The IBS guideline details the support, treatment and advice people should be offered by their GP and the circumstances that would require a referral to a specialist.
The osteoarthritis guideline details the diagnosis of OA, patient education, the place of exercise and physiotherapy, drug and non-drug treatments and indications for surgery.
The prostate cancer guideline details the tests, treatment, care and support that should be offered to men who have suspected or diagnosed prostate cancer.
Action: Clinicians who diagnose and treat patients with any of the above conditions will find these guidelines are a useful aid to management of these conditions.
Bookmark in del.icio.us
Safety First - UK style
The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update Issue 8 (PDF).This issue includes the following drug safety advice articles:
Ketoconazole: restricted indications
Telbivudine: risk of peripheral neuropathy
Trackback by Trusted.MD Network — March 5, 2008 #